Skip to content
AnalystLens
Back to MRNABalance Sheet

Moderna, Inc. Cash & Short-Term Investments 2015-2026 | MRNA

Annual FY2015–FY2025 · quarterly through Q1 FY2026

Latest annual · FY2025

$5.80B

−17.5%YoY vs FY2024Source: 10-KFY2025

From $159.0M in FY2015 to $5.80B in FY2025: 36.5× in 10 years.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY26$5.2B−12.9%Not reportedNot reportedNot reported
FY25$6.0B−29.9%$5.1B−39.5%$4.5B−34.4%$5.8B−17.5%
FY24$8.5B−4.7%$8.5B+0.1%$6.9B−9.6%$7.0B−18.6%
FY23$8.9B−11.6%$8.5B+7.4%$7.6B−9.0%$8.6B−12.9%
FY22$10.1B+30.6%$7.9B−1.3%$8.3B−6.4%$9.9B−7.8%

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date.

Key Statistics

Trend DirectionDeclining
CAGR

+4.7%

FY2020
$4.62B
FY2025
$5.80B

5 years selected · on the chart

01—History

Cash & Short-Term Investments History

Year-over-year comparison from 10-K annual reports

  11. $5.80B
YoY changeLargest recent move+318.8%in FY20Latest −17.5%

2 older moves run past ±150% (largest +1409.6%); point at, tap or drag across the bars to read one.

02—Ledger

Cash & Short-Term Investments, period by period

PeriodValueChangeSource
FY2025$5.80B−17.5%10-K
FY2024$7.03B−18.6%10-K
FY2023$8.63B−12.9%10-K
FY2022$9.90B−7.8%10-K
FY2021$10.74B+132.4%10-K
FY2020$4.62B+318.8%10-K
FY2019$1.10B−27.5%10-K
FY2018$1.52B+101.2%10-K
FY2017$756.0M+1409.6%10-K
FY2016$50.1M−68.5%10-K
FY2015$159.0M—10-K

03—Questions

What is Moderna, Inc.'s current cash & short-term investments?

Moderna, Inc. (MRNA) annual cash & short-term investments for 2025 was $5.80B, a 17.45% decline from 2024. Moderna, Inc. cash & short-term investments for the quarter ending March 31, 2026 was $5.21B.

What was Moderna, Inc.'s cash & short-term investments in 2024?

Moderna, Inc. annual cash & short-term investments for 2024 was $7.03B, a 18.55% decline from 2023.

What was Moderna, Inc.'s cash & short-term investments in 2023?

Moderna, Inc. annual cash & short-term investments for 2023 was $8.63B, a 12.90% decline from 2022.

What is Moderna, Inc.'s 5-year cash & short-term investments CAGR?

Moderna, Inc. cash & short-term investments grew at a compound annual growth rate (CAGR) of 4.65% from FY2020 to FY2025, going from $4.62B to $5.80B over 5 years.

Company
Moderna, Inc.
Ticker
MRNA
Sector
Healthcare
Industry
Biological Products, (No Diagnostic Substances)
View company profile →